- Home
- Life Sciences
- Pharmaceutical
- Pharmaceutical Analysis & Statistics in Japan, February 2013 (p3)
Talk to Geoffrey
+1 718 618 4302
Search inside this page
Publication dates
Publishers
- Global Data (701)
- Global Markets Direct (233)
- GBI Research (25)
- Business Monitor International (311)
- Global Research & Data Services (13)
-
- ICD Research (27)
- Canadean Ltd (12)
- Daedal Research (3)
- Global Industry Analysts (1)
- Datamonitor (159)
- Timely Data Resources Inc. (43)
- Espicom Business Intelligence (40)
- MarketLine (28)
- Global Industry Analyst (19)
- SCRIP Insights (17)
- Life Science Analytics (LSA) (15)
- VacZine Analytics Group Of Assay Advantage Ltd (15)
- Business Review (12)
- Euromonitor International (11)
- Visiongain (9)
- MarketLine Industry Guides (6)
- World Market Intelligence Ltd (6)
- Ken Research Private (5)
- Mintel (5)
- Frost & Sullivan (4)
- Infiniti Research Limited (4)
- Koncept Analytics (4)
- Pacific Bridge Medical (4)
- ABMRG (3)
- Aruvian's R'search (3)
- Currentpartnering (3)
- La Merie Publishing (3)
- Leatherhead Food Research (3)
- RNCOS (3)
- Obainfo (2)
- Barnes Reports (2)
- Kalorama Information (2)
- Renub Research (2)
- Urch Publishing (2)
- IData Research, Inc. (2)
- Arrowhead (1)
- BCC Research (1)
- Bioseeker (1)
- CCM International Limited (1)
- DrugPatentWatch - ThinkBiotech LLC (1)
- France Innovation Scientifique et Transfert (1)
- Greystone Research Associates (1)
- International Market Analysis Research and Consult (1)
- MarketsandMarkets (1)
- Pharmavision (1)
- Smart Research Insights (1)
- TriMark Publications (1)
data types
Free Market Research Guides to Download
Pharmaceutical Analysis & Statistics in Japan, February 2013 (p3)
You might be interested in: therapeutics, cancer, drug, more »
» Purchase Premium Reports
61-100 of about 1 500 reports
Allergies - Pipeline Review, H1 2013
- $ 2 000
- Industry report
- February 2013
- by Global Markets Direct
Allergies - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Allergies - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information ...
- Industries : Therapy
- Countries : Japan, World
Rotavirus Infections - Pipeline Review, H1 2013
- $ 2 000
- Industry report
- February 2013
- by Global Markets Direct
Rotavirus Infections - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Rotavirus Infections - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This ...
- Industries : Pathology
- Countries : World, China, Japan, Ghana
Drug and Medication in Japan: Dyslipidemia - Pipeline Review, H1 2012
- $ 2 000
- Industry report
- February 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Dyslipidemia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
- Industries : Therapy
- Countries : Japan, World
Encephalitis - Pipeline Review, H1 2013
- $ 2 000
- Industry report
- February 2013
- by Global Markets Direct
Encephalitis - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Encephalitis - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides ...
- Industries : Drug and Medication
- Countries : Japan, World, Venezuela, United States, China
Other Hematological Disorders - Pipeline Review, H1 2013
- $ 2 000
- Company report
- March 2013
- by Global Markets Direct
Other Hematological Disorders - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Other Hematological Disorders - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic ...
- Industries : Pathology
- Countries : Japan, World
Kidney Fibrosis - Pipeline Review, H1 2013
- $ 2 000
- Industry report
- February 2013
- by Global Markets Direct
Kidney Fibrosis - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Kidney Fibrosis - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides ...
- Industries : Therapy
- Countries : World, United States, Canada, Japan, China
World Therapy: Fibromyalgia - Pipeline Review, H1 2012
- $ 2 000
- Industry report
- February 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Fibromyalgia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
- Industries : Therapy
- Countries : World, Japan, United States
World Therapy: Glomerulonephritis - Pipeline Review, H1 2012
- $ 2 000
- Company report
- March 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Glomerulonephritis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...
- Industries : Pathology
- Countries : World, United States, Japan
World Drug and Medication: Tetanus - Pipeline Review, H1 2012
- $ 2 000
- Company report
- March 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Tetanus, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in ...
- Industries : Drug and Medication
- Countries : Japan, World, United States, Australia
World Pathology: Pertussis - Pipeline Review, H1 2012
- $ 2 000
- Company report
- March 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Pertussis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
- Industries : Drug and Medication
- Countries : Japan, World
Therapy in United States: Renal Anemia - Pipeline Review, H1 2012
- $ 2 000
- Company report
- March 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Renal anemia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
- Industries : Therapy
- Countries : United States, World, Japan
World Drug and Medication: Helicobacter Pylori Infections - Pipeline Review, H1 2012
- $ 2 000
- Industry report
- February 2013
- by Global Markets Direct
This report provides information on the therapeutic development for Helicobacter Pylori Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews ...
- Industries : Pathology
- Countries : Japan, World
World Pathology: Essential Thrombocythemia - Pipeline Review, H1 2012
- $ 2 000
- Industry report
- February 2013
- by Global Markets Direct
This report provides information on the therapeutic development for Essential Thrombocythemia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews ...
- Industries : Pathology
- Countries : Japan, World
Japan Pharmaceuticals and Healthcare Industry Update Quarter 2 2012
- $ 1 088
- Industry report
- February 2013
- by Business Monitor International
BMI View: Japan's pharmaceutical industry is highly attractive to both foreign and local drugmakers. All three sub-sectors - patented, generic and over-the-counter (OTC) medicines - are large and projection ...
- Industries : Drug and Medication
- Countries : Japan
Japan Pharmaceuticals and Healthcare Industry Update Quarter 3 2012
- $ 1 088
- Industry report
- May 2013
- by Business Monitor International
Includes 3 FREE quarterly updates BMI View: The prospects for Japan's pharmaceutical industry over the medium term are very positive. The country has one of the largest pensionable populations, healthcare ...
- Industries : Drug and Medication
- Countries : Japan
Global Irritable Bowel Syndrome (IBS) Market: Trends & Opportunities (2012-2017)
- $ 700
- Industry report
- April 2013
- by Daedal Research
Scope of the Report The report titled ?Global Irritable Bowel Syndrome Market: Trends and Opportunities (2012-17)' provides an in depth analysis of IBS market on a global level. The report presents the ...
- Industries : Pathology
- Countries : United States, World, Japan, Europe
Vaccine Market in Japan
- $ 652
- Industry report
- May 2013
- by Global Research & Data Services
This market research report offers a perspective on the actual market situation, trends and future outlook for vaccines in Japan. The study provides essential market information for decision-makers including: ...
- Industries : Drug and Medication
- Countries : Japan
Taisho Pharmaceutical Co., Ltd. (Symbol:4535) SWOT Analysis, Strategy, Revenues and Profits
- $ 300
- Company report
- March 2013
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Pharmaceutical
- Countries : Philippines, Japan, United States, Australia, Indonesia, Asia
Santen Pharmaceutical Co., Ltd. (Symbol:4536) SWOT Analysis, Strategy, Revenues and Profits
- $ 300
- Company report
- March 2013
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Pharmaceutical
- Countries : Japan, Finland, China, Netherlands
SymBio Pharmaceuticals Limited (4582) - Financial and Strategic SWOT Analysis Review
- $ 300
- Company report
- March 2013
- by Global Data
Summary SymBio Pharmaceuticals Limited (SymBio) is biopharmaceutical company. It developms drug candidates to target the underserved medical needs in the therapeutic areas of autoimmune, oncology and hematology ...
- Industries : Pharmaceutical
- Countries : South Korea, Japan
SUGI Holdings Co., Ltd. (Symbol:7649) SWOT Analysis, Strategy, Revenues and Profits
- $ 300
- Company report
- March 2013
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Pharmacies and Drug Stores
- Countries : Japan
Toyama Chemical Co., Ltd. - Strategic SWOT Analysis Review
- $ 300
- Company report
- March 2013
- by Global Data
Summary Toyama Chemical Co., Ltd.(Toyama Chemical) engages in the research, development, manufacture, and sale of pharmaceuticals in Japan and internationally. The company works on three fields,namely, ...
- Industries : Drug and Medication
- Countries : Japan
Medical & Biological Laboratories Co., Ltd. (4557) - Financial and Strategic SWOT Analysis Review
- $ 300
- Company report
- March 2013
- by Global Data
Summary MEDICAL&BIOLOGICAL LABORATORIES CO., LTD (MBL) is a pharmaceutical company, based in Japan. It operates through the research, development and manufacturing sectors of clinical diagnostics and basic ...
- Industries : Pathology
- Countries : Japan, United States, China
D. Western Therapeutics Institute, Inc. (4576) - Financial and Strategic SWOT Analysis Review
- $ 300
- Company report
- March 2013
- by Global Data
Summary D. Western Therapeutics Institute, Inc. (DWTI) is a Japan-based biotechnology company. The company is involved in the drug discovery and development business of new drug candidates for targeted ...
- Industries : Therapy
- Countries : Japan
Meiho Enterprise Co., Ltd. (Symbol:8927) SWOT Analysis, Strategy, Revenues and Profits
- $ 300
- Company report
- March 2013
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Pathology
- Countries : Japan
CHONG KUN DANG PHARMACEUTICAL CORP. (Symbol:001630) SWOT Analysis, Strategy, Revenues and Profits
- $ 300
- Company report
- March 2013
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Pharmaceutical
- Countries : South Korea, Japan
ASKA Pharmaceutical Co., Ltd. (4514) - Financial and Strategic SWOT Analysis Review
- $ 300
- Company report
- March 2013
- by Global Data
Summary ASKA Pharmaceutical Co., Ltd. (ASKA) is a pharmaceutical company, based in Japan. It manufactures sells, imports and exports pharmaceuticals, veterinary medicines, quasi-drugs, foods, and medical ...
- Industries : Drug and Medication
- Countries : Japan
Zeria Pharmaceutical Co Ltd (Symbol:4559) SWOT Analysis, Strategy, Revenues and Profits
- $ 300
- Company report
- March 2013
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Pharmaceutical
- Countries : Japan
Kobayashi Pharmaceutical Co Ltd (Symbol:4967) SWOT Analysis, Strategy, Revenues and Profits
- $ 300
- Company report
- March 2013
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Pharmaceutical
- Countries : Japan
Japan Poisonings, 30-44 Yrs, Male, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pharmaceutical
- Countries : Japan
Japan Poisonings, 60-69 Yrs, Male, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pharmaceutical
- Countries : Japan
Japan Poisonings, 0-4 Yrs, Female, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pharmaceutical
- Countries : Japan
Japan Poisonings, 70+ Yrs, Female, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pharmaceutical
- Countries : Japan
Japan Poisonings, 15-29 Yrs, Female, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pharmaceutical
- Countries : Japan
Japan Poisonings, 70+ Yrs, Male, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pharmaceutical
- Countries : Japan
aRigen Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- $ 250
- Company report
- April 2013
- by Global Data
Summary aRigen Pharmaceuticals, Inc. (aRigen) is a pharmaceutical company, based in Japan. It offers product such as antvirals, antoprotozoals and antibiotics. The company's product Antvirals ARYS-01 is ...
- Industries : Pathology
- Countries : Japan
Japan Poisonings, 45-59 Yrs, Male, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pharmaceutical
- Countries : Japan
Japan Poisonings, 5-14 Yrs, Female, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pharmaceutical
- Countries : Japan
Japan Poisonings, Total, Female, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pharmaceutical
- Countries : Japan
Japan Poisonings, 30-44 Yrs, Female, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pharmaceutical
- Countries : Japan
» Download Public Reports
About 700 reports
Company Report: Pathology in The United States and Japan for Year 2013
- Company report
- January 2013
- 4 pages
- by Corporation
... Associated with juxtapid treatment may be a risk factor for progressive liver disease, including steatohepatitis and cirrhosis. Measure alt, ast, alkaline phosphatase, and total bilirubin before initiating ...
Intercell Ag - Investment Analysis, December 2012
December 2012Eisai Inc. - Annual Report 2012
December 2012Company Report: Pharmaceutical In Japan For Year 2013
February 2013The Japanese Pharmaceutical Industry Brief
February 2013» Read our Company Profiles
30 CompaniesGlaxoSmithKline P.L.C.
United StatesNovartis Inc.
SwitzerlandGlaxoSmithKline PLC
United KingdomJohnson and Johnson
United StatesSanofi-Aventis Senegal
SenegalReportlinker.com © Copyright 2013. All rights reserved.
